These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6307026)

  • 1. Measles antibody levels from birth to 9 months of age in Nigerian infants.
    Abdurrahman MB; Greenwood BM; Olafimihan O; Whitle HC
    Afr J Med Med Sci; 1982 Sep; 11(3):113-5. PubMed ID: 6307026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of measles antibodies in Nigerian children aged 0-12 months and its relationship with maternal parity.
    Eghafona NO; Ahmad AA; Odama LE; Onuora C; Gosham LT; Emejuaiwe SO; Woghiren EI
    Epidemiol Infect; 1987 Oct; 99(2):547-50. PubMed ID: 3678407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles antibody levels in 3 to 9 months old infants.
    Dongre ST; Biranjan JR; Jalgaonkar SV; Polakhare JK
    Indian Pediatr; 1989 Aug; 26(8):775-9. PubMed ID: 2620978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
    Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
    Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects.
    Oyedele OO; Odemuyiwa SO; Ammerlaan W; Muller CP; Adu FD
    J Trop Pediatr; 2005 Feb; 51(1):45-8. PubMed ID: 15601649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
    Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
    J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.